Our data suggest that overexpression of mini-dystrophin in DMD muscle-derived cells affects either their proliferation or their differentiation by recruiting beta-dystroglycan to the cell membrane, which further triggers the downstream Erk1/2 signalling pathway. The gene discussed is MAPK3; the disease is Duchenne muscular dystrophy.